跳至主要内容
临床试验/ISRCTN18364209
ISRCTN18364209已完成未知

Influence of an omega-3 fatty acid triglyceride formulation on EPA and DHA appearance in human plasma after single dosing

BASF AS0 个研究点目标入组 20 人开始时间: 2019年7月12日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33046141/ results (added 14/10/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Healthy males and females
  • 2. Age 50 to 70 years
  • 3. Body mass index 20 to 35 kg/m2
  • 5. Not eating more than one oily fish meal per week
  • 6. Willing to adhere to the study protocol
  • 7. Able to provide written informed consent
  • 8. Omega-3 index (EPA+DHA in red blood cells) = 6.5 at screening visit

排除标准

  • 1. Diabetic (type 1 or type 2)
  • 2. Vegetarian or vegan and unwilling to consume capsules with a beef gelatine coating
  • 3. Use of prescribed medicine to control inflammation
  • 4. Smokers
  • 5. Alcohol consumption > 14 units per week
  • 5. Chronic gastrointestinal problems (e.g. IBD, IBS, celiac disease, cancer)
  • 6. Allergic to fish
  • 7. Use of fish oil or other oil supplement
  • 8. Participation in another clinical trial (currently or in the 12 weeks prior to study entry)
  • 9. Pregnancy or lactation
  • 10. Blood donations during 3 months prior to or during the study period

研究者

发起方
BASF AS

相似试验